US Stocks
/
Unicycive Therapeutics, Inc. Share Price

Unicycive Therapeutics, Inc. Share Price

NASDAQ: UNCY | Micro Cap
$4.12
+$0.06 (1.35%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Unicycive Therapeutics, Inc. Stock Performance

Open
$4.06
Prev. Close
$4.06
Circuit Range
N/A
Day Range
$4.06 - $4.20
Year Range
$3.99 - $8.74
Volume
34,517
Average Traded
$4.13

Unicycive Therapeutics, Inc. Share Price Today

As of 10 October 2026, Unicycive Therapeutics, Inc.'s share price is $4.12. The stock opened at $4.06, compared to its previous close of $4.06. During today's trading session, Unicycive Therapeutics, Inc.'s share price traded between $4.06 and $4.20, with an average price of $4.13. Over the past 52 weeks, the stock has recorded a high of $8.74 and a low of $3.99. In terms of performance, Unicycive Therapeutics, Inc.'s share price has declined by 46.28% over the last six months and is down 13.19% on a year-on-year basis.

Unicycive Therapeutics, Inc. Share Price Chart

$4.06$4.20
L
Show Current Price
H

Unicycive Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$65.37M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.26
Revenue (TTM)
$0.00
Return On Equity (TTM)
-66.12%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
71.38%

Unicycive Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$6.01-$14.67-$12.82-$1.72
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-144.09%12.61%86.58%

Unicycive Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.95$0.68$0.00$0.00
Net Profit-$18.06-$31.41-$37.82-$26.56
Net Profit Margin-1901.05%-4619.12%N/AN/A
Income ChangeN/A-73.92%-20.41%29.77%

About Unicycive Therapeutics, Inc.

Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Unicycive Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$4.71
$4.10
-12.77%
Sep 2026
$5.17
$4.70
-14.39%
Aug 2026
$5.00
$5.49
+9.47%
Jul 2026
$4.58
$5.01
+6.03%
Jun 2026
$7.50
$4.73
-35.73%
May 2026
$7.72
$7.36
-3.92%
Apr 2026
$6.78
$7.66
+16.50%
Mar 2026
$6.70
$6.58
-5.26%
Feb 2026
$6.00
$6.94
+16.54%
Jan 2026
$5.79
$5.96
+3.21%
Dec 2025
$6.42
$5.77
-10.68%
Nov 2025
$4.74
$6.46
+36.29%

UNCY Share Price FAQs

What is Unicycive Therapeutics, Inc. share price today?

chevron-up
Unicycive Therapeutics, Inc. share price today is $4.12 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Unicycive Therapeutics, Inc. stock?

chevron-up
The 52 week high of Unicycive Therapeutics, Inc. stock is $8.74, while the 52 week low is $3.99 as of 10 Oct '26.

What is UNCY's market capitalisation today?

chevron-up
UNCY market capitalisation is $65.37M as of October 10, 2026, at 8:17 am IST.

What is UNCY's net income for the last quarter?

chevron-up
UNCY's net income for the last quarter is -1.72B USD.

What is the 5 year returns of UNCY?

chevron-up
The 5 year returns of UNCY is -85.76% as on 10 Oct '26.

What is the high & low stock price of UNCY today?

chevron-up
UNCY stock price hit a high of $4.20 and low of $4.06 as of 10 Oct '26.

Can I buy UNCY shares in India?

chevron-up
Yes. You can buy UNCY in India by opening an international trading account.